management

Jed Latkin

CEO

Jed was appointed CEO of Windtree Therapeutics on December 1, 2024, and will continue to serve as a member of the Board which he has been a member of since October 2024. He has nearly three decades of financial and biotech experience, including as CEO of a public biotech company. As the CEO of Navidea Biopharmaceuticals, Jed  executed deals and raised substantial funds, and also held the position there as the Chief Financial Officer. Most recently, he performed as both the Chief Operating Officer and Head of Finance at ProPhase Labs for the past two years, conducting deals and managing broad aspects of the business. Jed’s experience also includes serving as a CEO of Black Elk Energy Offshore in 2014 as part of Nagel Avenue Capital, which he joined after working for over ten years on Wall Street with a variety of investment banking organizations and funds, including ING, Morgan Stanley and Citigroup Securities.

Jed earned a Master of Business Administration from Columbia University and a Bachelor of Science degree from Rutgers University, graduating with honors and Phi Beta Kappa.

Eric Curtis

PRESIDENT AND CHIEF OPERATING OFFICER

Eric joined Windtree in March 2020 having most-recently served as the Chief Executive Officer and President of Centurion Biopharma Corp. (Centurion), an oncology research and development company and President and Chief Operating Officer of CytRX Corporation, a biopharmaceutical company and Centurion’s parent company, since February 2018. Prior to joining Centurion, Eric served as Principal of Curtis Biopharm Consulting, where he provided strategic consultancy services to a variety of healthcare-focused companies, including Windtree, from May 2016 to January 2018. From 2014 to May 2016, he held the position of President, U.S. Commercial at Aegerion Pharmaceuticals (now Novelion Therapeutics). Prior to those roles, Eric was VP/GM of the Cardiopulmonary BU at Bayer, Global Commercial Leader and VP of Marketing at GlaxoSmithKline and held senior marketing and sales roles at Johnson & Johnson.

Eric earned a Master of Business Administration from Pennsylvania State University as well as a Bachelor of Science degree from the University of Pittsburgh.

George Cox

Vice President of Technical Operations

George Cox was appointed Windtree’s Vice President of Technical Operations in April 2008 and is responsible for the global manufacturing, quality and logistics of clinical drugs and supplies for the company.

Mr. Cox brings over 35 years of experience in global manufacturing, clinical supply and international cold chain logistics. Prior to joining Windtree, Mr. Cox served as Senior Director of Supply Chain for Auxilium Pharmaceuticals and at MedImmune, Inc. While at MedImmune, he was instrumental in obtaining government funding for the then pandemic preparedness. Before this position, Mr. Cox held various positions of increasing responsibilities at Rhone-Polenc Rorer Pharmaceuticals, Uniform Tubes and Proctor-Silex. His experience spans the pharmaceutical and biotech industries in small start-ups, as well as large pharma.

Mr. Cox earned his Bachelor of Science in Accounting at Villanova University.